BeStock  
Stocks › Biotechnology › VERA

Vera Therapeutics VERA

US equityMarket cap rank #2729Biotechnology
$25.45 −$1.30 (-4.86%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $24.88 -2.24%
Open$26.37
Prev close$26.75
Day range$25.16 – $27.15
Volume1.37M
Market cap$1.84B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$10.28M
Operating profit-$95.70M-14.0% YoY
Net profit-$93.71M-16.7% YoY
Diluted EPS-$1.30-3.2% YoY
Free cash flow-$99.59M-60.5% YoY
Operating cash flow-$99.18M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$10.3MSep '26

Net profit, last 8 quarters

$-43.4MDec '24$-51.7MMar '25$-76.5MJun '25$-80.3MSep '25$-91.1MDec '25$-121.0MMar '26$-109.5MJun '26$-93.7MSep '26

Diluted EPS by quarter

-0.72Dec '24-0.81Mar '25-1.20Jun '25-1.26Sep '25-1.39Dec '25-1.69Mar '26-1.52Jun '26-1.30Sep '26

Free cash flow by quarter

$-39.8MDec '24$-54.6MMar '25$-55.0MJun '25$-62.0MSep '25$-70.1MDec '25$-106.7MMar '26$-100.4MJun '26$-99.6MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Gross margin67.9%
Operating margin-4,160.1%
Net margin-4,041.2%
Return on equity-113.5%
Return on assets-84.5%
Return on invested capital-97.0%
Current ratio7.91
Liabilities / assets28.5%
Cash & investments$384.04M
Total debt$76.79M
Net cash (debt)$307.25M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $10.28M – – – –
Total Operating Revenue $10.28M $0.00 $0.00 $0.00 $0.00
Cost of Revenue $3.30M – – – –
Gross Profit $6.98M – – – –
Operating Expense $102.68M $112.49M $125.13M $315.47M $94.21M
Selling and Admin Expenses $61.43M $52.41M $39.12M $100.22M $34.90M
-Selling & Marketing Expense $15.87M – – – –
-General & Admin Expense $45.57M $52.41M $39.12M $100.22M $45.68M
Research & Development $41.25M $60.08M $86.01M $215.26M $59.31M
Operating Profit -$95.70M -$112.49M -$125.13M -$315.47M -$94.21M
Net Non-Operating Interest Income (Expense) $2.46M $3.50M $4.53M $16.95M $3.61M
Non-Operating Interest Income $4.34M $5.35M $6.36M $24.48M $5.52M
Non-Operating Interest Expense $1.87M $1.85M $1.82M $7.53M $1.90M
Other Income (Expense) -$472,000.00 -$483,000.00 -$432,000.00 -$1.09M -$503,000.00
Other Non-Operating Income (Expenses) -$472,000.00 -$483,000.00 -$432,000.00 -$1.09M -$503,000.00
Pretax Profit -$93.71M -$109.47M -$121.03M -$299.61M -$91.10M
Net Profit -$93.71M -$109.47M -$121.03M -$299.62M -$91.10M
Profit from Continuing Operations -$93.71M -$109.47M -$121.03M -$299.62M -$91.10M
Net Income to Parent Company -$93.71M -$109.47M -$121.03M -$299.62M -$91.10M
Net Income to Common Stockholders -$93.71M -$109.47M -$121.03M -$299.62M -$91.10M
Basic EPS -$1.30 -$1.52 -$1.69 -$4.66 -$1.39
Diluted EPS -$1.30 -$1.52 -$1.69 -$4.66 -$1.39
Tax – – – $1,000.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $465.75M $532.98M $621.74M $734.73M $734.73M
Total Current Assets $441.29M $527.49M $615.80M $728.88M $728.88M
Cash and Cash Equivalents & Short-Term Investments $384.04M $499.16M $596.76M $714.59M $714.59M
-Cash and Cash Equivalents $55.32M $48.88M $114.35M $354.73M $354.73M
-Short Term Investments $328.72M $450.29M $482.41M $359.86M $359.86M
Receivables $14.57M $3.93M $3.91M $3.29M $3.29M
-Accounts Receivable $11.98M – – – –
-Accrued Interest Receivable $2.59M $3.93M $3.91M $3.29M $3.29M
Prepaid Assets $28.69M $20.20M $12.64M $8.47M $8.47M
Inventory $7.08M – – – –
Other Current Assets $6.91M $4.21M $2.50M $2.54M $2.54M
Total Non-Current Assets $24.47M $5.49M $5.94M $5.85M $5.85M
Goodwill and Other Intangible Assets $20.50M – – – –
-Other Intangible Assets $20.50M – – – –
Other Non-Current Assets $3.97M $5.49M $5.94M $2.55M $2.55M
Total Liabilities $132.57M $125.23M $122.04M $130.21M $130.21M
Total Current Liabilities $55.78M $48.32M $45.15M $53.46M $53.46M
Payables $20.17M $14.57M $13.91M $21.90M $21.90M
-Accounts Payable $20.17M $14.57M $13.91M $21.90M $21.90M
Current Accrued Expenses $32.78M $31.02M $27.77M $29.64M $29.64M
Other Current Liabilities $2.82M $2.73M $3.47M $1.37M $1.37M
Total Non-Current Liabilities $76.79M $76.91M $76.89M $76.76M $76.76M
Long Term Debt and Capital Lease Obligation $76.79M $76.91M $76.89M $76.76M $76.76M
-Long Term Debt $75.43M $75.23M $75.03M $74.84M $74.84M
-Long Term Capital Lease Obligation $1.36M $1.68M $1.86M $1.92M $1.92M
Total Equity $333.19M $407.76M $499.70M $604.52M $604.52M
Stockholders' Equity $333.19M $407.76M $499.70M $604.52M $604.52M
Capital Stock $72,000.00 $72,000.00 $72,000.00 $71,000.00 $71,000.00
-Common Stock $72,000.00 $72,000.00 $72,000.00 $71,000.00 $71,000.00
Additional Paid-In Capital $1.42B $1.40B $1.38B $1.36B $1.36B
Retained Earnings -$1.09B -$991.37M -$881.90M -$760.87M -$760.87M
Gains/Losses Not Affecting Retained Earnings -$704,000.00 -$403,000.00 -$156,000.00 $786,000.00 $786,000.00
Net PPE – – – $3.30M $3.30M
-Gross PPE – – – $3.30M $3.30M
-Due to Related Parties Current – – – $3,000.00 $3,000.00
Short-Term Debt and Capital Lease Obligation – – – $549,000.00 $549,000.00
-Current Capital Lease Obligation – – – $549,000.00 $549,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$99.18M -$100.25M -$106.50M -$241.10M -$69.99M
Net cash flow from continuing operations -$99.18M -$100.25M -$106.50M -$241.10M -$69.99M
Net Income from Continuing Operations -$93.71M -$109.47M -$121.03M -$299.62M -$91.10M
Depreciation & Depletion & Amortization $823,000.00 $132,000.00 $140,000.00 $468,000.00 $135,000.00
Other Non-Cash Items $778,000.00 $766,000.00 $15.76M $4.11M $750,000.00
Change in Working Capital -$21.74M -$6.44M -$13.73M $22.99M $10.36M
-Change in Prepaid Assets -$9.78M -$9.43M -$5.14M -$3.93M -$422,000.00
-Change in Payables and Accrued Expense $7.11M $3.17M -$8.40M $28.35M $10.83M
-Change in Other Current Liabilities -$4,000.00 -$187,000.00 -$182,000.00 -$1.48M -$100,000.00
Net cash flow from investing $101.91M $32.86M -$137.82M $194.29M $80.66M
Net Cash Flow from Continuing Investing Activities $101.91M $32.86M -$137.82M $194.29M $80.66M
Net PPE Purchase and Sale $0.00 $0.00 -$23,000.00 -$630,000.00 -$102,000.00
Net Intangibles Purchase and Sale -$409,000.00 -$114,000.00 -$150,000.00 – –
Net Investment Purchase and Sale $122.32M $32.97M -$122.64M $195.72M $80.77M
Net Other Investing Changes -$20.00M $0.00 -$15.00M -$800,000.00 $0.00
Financing Cash Flow $3.71M $1.92M $3.94M $308.90M $286.28M
Net Cash Flow from Continuing Financing Activities $3.71M $1.92M $3.94M $308.90M $286.28M
Net Issuance Payments Of Debt $0.00 – – $23.34M $0.00
Proceeds from Stock Option Exercised $3.71M $1.92M $3.94M $6.98M $4.19M
Ending Cash Balance $55.32M $48.88M $114.35M $354.73M $354.73M
Net Change in Cash $6.45M -$65.48M -$240.37M $262.08M $296.95M
Beginning Cash Balance $48.88M $114.35M $354.73M $92.65M $57.77M
Free Cash Flow -$99.59M -$100.37M -$106.67M -$241.73M -$70.10M
-Change in Other Current Assets – $0.00 $0.00 $51,000.00 $1,000.00
Net Common Stock Issuance – – – $300.50M $300.50M
Net Other Financing Charges – – – -$21.92M -$18.41M

Discussion

No comments yet — be the first to weigh in on VERA.

Sign in to join the discussion.

Scroll to Top